UPDATE : Thursday, December 13, 2018
상단여백
[News Focus] Celltrion to accelerate US entry on imminent FDA approval
Cellrion is expected to accelerate its move to enter the U.S. market with a...
by So Jae-hyeon  |  2018-10-12 15:40
라인
Bridge Bio completes phase-1 study for ulcerative colitis drug in US
Bridge Biotherapeutics said Friday that it has completed phase-1 clinical t...
by Lee Han-soo  |  2018-10-12 13:38
라인
Boryung to export anticancer drugs to Philippine
Boryung Pharmaceutical said Friday that it has signed a deal with Endure Me...
by Lee Han-soo  |  2018-10-12 13:26
라인
[News Focus] Authorities close in on drug firm owners in bribery case
The issue of illegal rebates is stirring the Korean pharmaceutical sector, ...
by So Jae-hyeon  |  2018-10-11 16:33
라인
YD Life Science wins source tech for anti-cancer gene therapy
YD Life Science said Wednesday that it has signed a technology transfer agr...
by Lee Han-soo  |  2018-10-11 14:46
라인
BMS to test cabiralizumab+nivolumab for pancreatic cancer
Bristol-Myers Squibb is soon to conduct phase-2 trials in Korea on its immu...
by Lee Hye-seon  |  2018-10-11 14:23
라인
Anticipation grows for Lenvima as new liver cancer drug
Eisai Korea’s Lenvima (lenvatinib), recently approved as a first-line treat...
by Nam Doo-hyun  |  2018-10-11 11:44
라인
Kukje Pharm CEO, executives booked for bribing doctors
A midsize Korean pharmaceutical company has been embroiled in an illegal re...
by So Jae-hyeon  |  2018-10-10 15:31
라인
Hanmi unveils test results for asthma-rhinitis combination drug in US
Hanmi said Wednesday that it has presented its phase 3 clinical trial resul...
by Lee Han-soo  |  2018-10-10 12:08
라인
‘Medytox performance depends on Chinese regulations on peddlers’
Medytox’s performance in the fourth quarter will rely on the Chinese govern...
by Nam Doo-hyun  |  2018-10-08 16:59
라인
Abbott’s hepatitis B antibody reagent recalled due to error
The government ordered Korea Abbott to recall its hepatitis B antibody reag...
by Lee Hye-seon  |  2018-10-08 15:52
라인
Amantadine sulfate to lose indication for influenza A virus treatment
The government said it would change approval conditions for two pharmaceuti...
by Lee Hye-seon  |  2018-10-08 15:49
라인
Pharmaceuticals seek fresh start with new CEOs
Several pharmaceutical and biotech firms have appointed a new CEO or a vice...
by So Jae-hyeon  |  2018-10-05 15:44
라인
Allergan’s eye implant recalled due to foreign substance
Allergan is recalling Ozurdex Intravitreal Implant 700㎍ (ingredient: dexame...
by Lee Hye-seon  |  2018-10-05 13:53
라인
Daewoong to refile clinical trial plan on botulinum toxin in China
Daewoong Pharmaceutical has changed its strategy of entering the Chinese ma...
by So Jae-hyeon  |  2018-10-05 12:00
라인
GC LabCell seeks to expand indication of natural killer cell-based therapy
GC LabCell said Thursday it has received regulatory approval for a phase-1/...
by So Jae-hyeon  |  2018-10-04 14:51
라인
BMS to start phase-3 test on oral psoriasis treatment in Korea
Bristol-Myers Squibb said it would begin global phase-3 trials on BMS-98616...
by Lee Hye-seon  |  2018-10-01 15:09
라인
Pharma event to showcase AI-based solutions for new drug development
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) a...
by So Jae-hyeon  |  2018-10-01 13:34
라인
Genexine unveils clinical trial results for persistent growth hormone
Genexine said Friday that it has presented the phase 2 clinical trial resul...
by Lee Han-soo  |  2018-09-28 16:46
라인
Original hypertension drugs enjoy sales growth after valsartan recall
Original hypertension treatments by multinational pharmaceuticals achieved ...
by So Jae-hyeon  |  2018-09-28 15:55
여백
여백
여백
Back to Top